Pharmacotherapeutics for advanced practice: A practical
approach
(3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.
o
Chapter 36, “Osteoarthritis and Rheumatoid Arthritis”
(pp. 538–559)
o
Chapter 37, “Fibromyalgia” (pp. 560–567)
o
Chapter 45, “Diabetes Mellitus” (pp. 696–714)
o
Chapter 46, “Thyroid Disorders” (pp. 715–729)
•
Ben-Zacharia, A. (2011). Therapeutics for multiple sclerosis
symptoms.
The Mount Sinai Journal of Medicine
,
78
(2), 176–
191.
•
Kargiotis, O., Paschali, A., Messinis, L., & Papathanasopoulos,
P. (2010). Quality of life in multiple sclerosis: Effects of current
treatment options.
International Review of Psychiatry
,
22
(1),
67–82.
•
Peterson, K., Silverstein, J., Kaufman, F., & Warren-Boulton,
E. (2007). Management of type 2 diabetes in youth: An update.
American Family Physician
,
76
(5), 658–664.
•
Drugs.com. (2012). Retrieved from
Media
•
Laureate Education, Inc. (Executive Producer). (2012).
The
endocrine system and diabetes
. Baltimore, MD: Author.
